The aim of our retrospective analysis was to investigate the potential of quantitative and qualitative parameters from 68Ga-PSMA-11 PET to serve as non-invasive imaging biomarkers to predict BCR in primary prostate cancer after RP allowing for ancillary preoperative risk stratification. The gene discussed is FOLH1; the disease is Familial prostate cancer.